Life Sciences Tools and Services
Company Overview of BioClinica, Inc.
BioClinica, Inc. provides integrated clinical research technology solutions to pharmaceutical, biotechnology, medical device companies, and contract research organizations. Its products and services include medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools, and clinical trial management software solutions. The company also offers application hosting, consulting, and customer support services. Its clinical trial solutions enable pharmaceutical and biotech companies to collect, clean, process, and store the data generated in clinical trials. T...
826 Newtown-Yardley Road
Newtown, PA 18940-1721
Founded in 1987
Key Executives for BioClinica, Inc.
Senior Vice President of Operations
Executive Vice President and President of eClinical Division
Executive Vice President and President of Imaging Core Lab Division
Compensation as of Fiscal Year 2013.
BioClinica, Inc. Key Developments
Bioclinica, Inc. Announces Successful Completion of First Phase of Big Data Research Project to Develop Novel Algorithms for Automated Analysis of Medical Images in Clinical Trials
Nov 12 13
BioClinica, Inc. announced the successful completion of the first phase of a big data research project to develop novel algorithms for the automated analysis of medical images in clinical trials. This work was made possible by a strategic partnership with the Center for Dynamic Data Analytics (CDDA), a National Science Foundation (NSF) sponsored cooperative research center focused on developing scalable methods for handling large amounts of complex industry-related data. The BioClinica-CDDA project is part of the 'National Big Data and Research and Development Initiative', aimed at addressing the challenges and opportunities of 'Big Data' and is highlighted by the Obama Administration as a high-impact collaboration promoting 'Data to Knowledge to Action.' Under the research project entitled 'Quantitative Tissue Assessment', scientific experts from BioClinica and Rutgers University worked together to define, direct and develop important quantitative tools for the clinical assessment of new therapies for muscle, liver and spleen diseases. These tools enable the extraction of quantitative data from medical images with increased automation and precision. The quantification of muscle tissue is becoming an increasingly important measurement in aging populations for assessing sarcopenia and other musculoskeletal diseases. Additionally, tools for the evaluation of liver and spleen are needed for clinical trials for non-alcoholic steato-hepatitis (NASH) and for a number of orphan diseases. On the heels of the success of the 'Quantitative Tissue Assessment' project, BioClinica and the CDDA have additional projects in the works, including the development of scalable algorithms for automated image analysis for additional therapeutic areas and unmet medical needs.
David S. Herron Joins BioClinica, Inc. as Executive Vice President and President of Imaging Core Lab Division
Jul 16 13
BioClinica, Inc. announced the appointment of David S. Herron to the position of Executive Vice President and President of the company's Imaging Core Lab Division. Mr. Herron is responsible for the global strategic planning and operations of BioClinica's medical imaging management solutions which include software and services for the electronic transfer, management, and independent review of medical images for clinical trials. Prior to joining BioClinica, Mr. Herron served as an Executive in Residence with DW Healthcare Partners, a private equity firm focused on healthcare opportunities. Before DW Healthcare, he spent four years at CCBR-SYNARC, from 2006 to 2010. Mr. Herron began as VP of Sales and progressed to serve as Chief Operating Officer during his final two years with CCBR-SYNARC. Throughout his career, Mr. Herron has held positions of increasing responsibility in a variety of healthcare industries including clinical research organizations, centralized imaging laboratories, healthcare information technologies, managed care, managed pharmacy, and international consulting firms focused on information technologies, healthcare and time-loss management.
Grunenthal Selects BioClinica, Inc.'s New Trident IWR/IVR Solution
Jul 2 13
BioClinica, Inc. has announced that Grunenthal GmbH will again utilize the latest enhancements in Trident IWR/IVR for a global clinical study on pain medication. The integration of Trident into Grunenthal's clinical trial process is already underway. The new interactive web and voice response technology replaces a manual system for managing inventory, returns, and accountability of controlled substances.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 30, 2013